09.08.2012 • TopicsLondon 2012WileyOlympic games

Wiley: Publisher for the Olympic Games

London 2012 Olympic and Paralympic Games: The Official Commemorative Book and...
"London 2012 Olympic and Paralympic Games: The Official Commemorative Book" and "Making History at London 2012" will be published in October 2012

Millions of people around the world have been drawn into the excitement of the Olympic Games, cheering on their home teams and marveling at the athleticism and accomplishments of the participants. In 2010, Wiley achieved the distinction of being the first company in history to publish all the official books for the Olympic Games, a portfolio of commemorative publications and visitor guides for the Winter Games and Paralympic Winter Games in Vancouver, Canada. In 2012, Wiley is playing an even more important role as the official publisher of nine books for the London Games, including the official commemorative book.

The Olympic rings are one of the world's most powerful brands, and the London Games, touted as the first social media Olympics, will extend the brand as never before. Wiley's association with London 2012 is an extraordinary opportunity to showcase expertise in publishing high-quality, visually stunning print and digital books while reaching a vast new audience beyond traditional markets. The nine books comprising the program target the middle to high-end market, with high production values, compelling layouts, and copious illustrations.

Watch this online exhibit to see all of Wiley's London 2012 publications, including the all-important official commemorative book.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.